SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-19-000034
Filing Date
2019-01-24
Accepted
2019-01-23 18:49:48
Documents
46
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zander123118form10q.htm 10-Q 360251
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8510
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8388
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6231
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6399
12 EXHIBIT 10.1 ex10_1.htm EX-10.1 216717
  Complete submission text file 0001607062-19-000034.txt   1861383

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE zander-20181231.xml EX-101.INS 206233
7 XBRL SCHEMA FILE zander-20181231.xsd EX-101.SCH 23566
8 XBRL CALCULATION FILE zander-20181231_cal.xml EX-101.CAL 28233
9 XBRL DEFINITION FILE zander-20181231_def.xml EX-101.DEF 61485
10 XBRL LABEL FILE zander-20181231_lab.xml EX-101.LAB 118666
11 XBRL PRESENTATION FILE zander-20181231_pre.xml EX-101.PRE 113889
Mailing Address 4700 SPRING ST LA MESA CA 91942-0274
Business Address 4700 SPRING ST LA MESA CA 91942-0274 6192279192
Zander Therapeutics, Inc (Filer) CIK: 0001718644 (see all company filings)

IRS No.: 474321638 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-220790 | Film No.: 19538376
SIC: 2834 Pharmaceutical Preparations